CDC: Racial Disparity Seen With Lupus-Related Deaths
Mortality from systemic lupus erythematosus (SLE) is significantly higher among blacks.
Systemic Lupus Erythematosus
Adverse Childhood Experiences Associated With Worse Lupus Outcomes
Adverse childhood experiences (ACEs) are associated with worse patient-reported systemic lupus erythematosus (SLE) outcomes.
Lupus Affects Emotional, Mental Well-Being of Patients
More than 60 percent of patients with lupus report that the disease has a large effect on their emotional and mental well-being.
First Treatment for Children With Systemic Lupus Erythematosus Gets FDA Approval
The Food and Drug Administration (FDA) has approved the intravenous (IV) formulation of Benlysta (belimumab; GlaxoSmithKline) for the treatment of pediatric patients ≥5 years old with active, autoantibody-positive, systemic lupus erythematosus (SLE) who are receiving standard therapy.
The Association Between Skin Diseases and Metabolic Syndrome
Investigators examine the association between various skin conditions and metabolic syndrome.
Second Antimalarial Agent May Be Effective in Cutaneous Lupus Despite Failure of Initial Agent
An observational study evaluated the effect of switching from one antimalarial agent to another agent in cutaneous lupus erythematosus after initial therapy was ineffective or not tolerated.
Next post in General Dermatology
